Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
Cash from Operating Activities
Prothena Corporation PLC
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prothena Corporation PLC
NASDAQ:PRTA
|
Cash from Operating Activities
-$133.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-15%
|
|
Alkermes Plc
NASDAQ:ALKS
|
Cash from Operating Activities
$401.4m
|
CAGR 3-Years
69%
|
CAGR 5-Years
32%
|
CAGR 10-Years
11%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Cash from Operating Activities
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Cash from Operating Activities
-$194.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prothena Corporation PLC's Cash from Operating Activities?
Cash from Operating Activities
-133.9m
USD
Based on the financial report for Dec 31, 2023, Prothena Corporation PLC's Cash from Operating Activities amounts to -133.9m USD.
What is Prothena Corporation PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-15%
Over the last year, the Cash from Operating Activities growth was -23%. The average annual Cash from Operating Activities growth rates for Prothena Corporation PLC have been -19% over the past three years , -36% over the past five years , and -15% over the past ten years .